Author:
Gassull Miquel A.,Cabré Eduard
Reference39 articles.
1. Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977;2:892–5.
2. Goldman P, Peppercorn MA. Drug therapy: sulfasalazine. N Engl J Med. 1975;293:20–3.
3. Das KM, Dubin R. Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinet. 1976;1:406–25.
4. Hawkey CJ, Boughton-Smith NK, Whittle BJ. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci. 1985;30:1161–5.
5. Ahnfelt-Ronne I, Nielsen OH, Bukhave K, Elmgreen J. Sulfasalazine and its anti-inflammatory metabolite, 5-aminosalicylic acid: effect on arachidonic acid metabolism in human neutrophils, and free radical scavenging. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:918–22.